Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
- 17 March 2011
- journal article
- perspective
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 54 (8), 2529-2591
- https://doi.org/10.1021/jm1013693
Abstract
No abstract availableThis publication has 338 references indexed in Scilit:
- Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH InhibitorACS Medicinal Chemistry Letters, 2010
- Structure−Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)Journal of Medicinal Chemistry, 2010
- Structure of Human G Protein-Coupled Receptor Kinase 2 in Complex with the Kinase Inhibitor BalanolJournal of Medicinal Chemistry, 2010
- Iminodiacetic-phosphoramidates as metabolic prototypes for diversifying nucleic acid polymerization in vivoNucleic Acids Research, 2010
- Energetics of Displacing Water Molecules from Protein Binding Sites: Consequences for Ligand OptimizationJournal of the American Chemical Society, 2009
- Binding and Inactivation Mechanism of a Humanized Fatty Acid Amide Hydrolase by α-Ketoheterocycle Inhibitors Revealed from Cocrystal StructuresJournal of the American Chemical Society, 2009
- Harnessing Nature’s Insight: Design of Aspartyl Protease Inhibitors from Treatment of Drug-Resistant HIV to Alzheimer’s DiseaseJournal of Medicinal Chemistry, 2009
- Chiral Squaramide Derivatives are Excellent Hydrogen Bond Donor CatalystsJournal of the American Chemical Society, 2008
- Polymerase-catalyzed synthesis of DNA from phosphoramidate conjugates of deoxynucleotides and amino acidsNucleic Acids Research, 2007
- Delineation of a Fundamental α-Ketoheterocycle Substituent Effect for Use in the Design of Enzyme InhibitorsJournal of the American Chemical Society, 2006